• ورود به سامانه
      مشاهده مورد 
      •   صفحهٔ اصلی
      • نشریات انگلیسی
      • Middle East Journal of Cancer
      • Volume 11, Issue 1
      • مشاهده مورد
      •   صفحهٔ اصلی
      • نشریات انگلیسی
      • Middle East Journal of Cancer
      • Volume 11, Issue 1
      • مشاهده مورد
      JavaScript is disabled for your browser. Some features of this site may not work without it.

      Role of Glutathione S-transferase (GSTM1, GSTT1) and CYP1A1 (cytochrome p450) Gene Polymorphisms in Susceptibility to Acute Myeloid Leukemia

      (ندگان)پدیدآور
      Mortazavi, YousefRahimi, RobabAzimi, FatemehRostami, ShahrbanoMoghimi, MinooshFaghihzadeh, SoghratMazloomzadeh, Saeide
      Thumbnail
      نوع مدرک
      Text
      Original Article
      زبان مدرک
      English
      نمایش کامل رکورد
      چکیده
      Background: Acute myeloid leukemia (AML) may originate from the combination of genetic susceptibility factors and environmental exposure. The aim of this study was to investigate the association of GSTM1 and GSTT1 null genotypes and CYP1A1*2A allele with susceptibility to AML in an Iranian population. Method: In this case-control study, 200 patients with AML and 200 normal individuals as controls were included. GSTM1 and GSTT1 null genotypes were amplified using multiplex PCR and CYP1A1*2A polymorphisms were genotyped by PCR-RFLP. Result: The frequency of GSTM1 null genotype was significantly higher in the control group compared to the case group. The frequency of GSST1 null genotype was significantly lower in the controls. No association was observed between the studied CYP1A1*2A variant and the risk of acute myeloid leukemia. The combination of GSTT1 null genotype and CYP1A1 *2A AA and AC alleles further increased the risk of AML. Conclusion: GSTT1 null genotype can increase the risk of AML, particularly when combined with CYP1A1*2A allele. GSTM1 null genotype can also play a protective role and reduce the risk of AML. However, further studies are required on a larger number of patients.
      کلید واژگان
      GSST1
      GSTM1
      CYP1A1
      AML

      شماره نشریه
      1
      تاریخ نشر
      2020-01-01
      1398-10-11
      ناشر
      Shiraz University of Medical Sciences
      سازمان پدید آورنده
      Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
      Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
      Eye Research Center, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
      Hematology, Oncology, and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran
      Department of Hematology and Oncology, Valie-asr Hospital, Zanjan University of Medical Sciences, Zanjan, Iran
      Department of Epidemiology and Statistics, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
      Department of Epidemiology and Statistics, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

      شاپا
      2008-6709
      2008-6687
      URI
      https://dx.doi.org/10.30476/mejc.2019.78642.0
      https://mejc.sums.ac.ir/article_45948.html
      https://iranjournals.nlai.ir/handle/123456789/168974

      مرور

      همه جای سامانهپایگاه‌ها و مجموعه‌ها بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌هااین مجموعه بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌ها

      حساب من

      ورود به سامانهثبت نام

      تازه ترین ها

      تازه ترین مدارک
      © کليه حقوق اين سامانه برای سازمان اسناد و کتابخانه ملی ایران محفوظ است
      تماس با ما | ارسال بازخورد
      قدرت یافته توسطسیناوب